Is neuregulin 1 involved in determining cerebral volumes in schizophrenia? Preliminary results showing a decrease in superior temporal gyrus volume

Neuropsychobiology

Volumn 65, Issue 3, 2012, Pages 119-125

  Tosato, Sarah ^a   Bellani, Marcella ^a   Bonetto, Chiara ^a   Ruggeri, Mirella ^a   Perlini, Cinzia ^a   Lasalvia, Antonio ^a   Marinelli, Veronica ^a   Rambaldelli, Gianluca ^a   Cristofalo, Doriana ^a   Bertani, Mariaelena ^a   Zanoni, Martina ^a   Lazzarotto, Lorenza ^a   Cerini, Roberto ^a   Pozzi Mucelli, Roberto ^a   Tansella, Michele ^a   Dazzan, Paola ^d   Di Forti, Marta ^d   Murray, Robin M ^d   Collier, David A ^d   Brambilla, Paolo ^b,c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Magnetic resonance imaging; Neuregulin 1; Schizophrenia; Superior temporal gyrus; White matter

Indexed keywords

DNA; NEU DIFFERENTIATION FACTOR;

ARTICLE; BLOOD SAMPLING; BRAIN SIZE; CHRONIC DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL GYRUS; WHITE MATTER;

ADULT; ANALYSIS OF VARIANCE; COHORT STUDIES; FEMALE; FUNCTIONAL LATERALITY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MONTE CARLO METHOD; NEUREGULIN-1; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SOCIAL WELFARE; TEMPORAL LOBE; YOUNG ADULT;

EID: 84857474046     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000330584     Document Type: Article

References (72)

1. Kim JJ, Crespo-Facorro B, Andreasen NC, O'Leary DS, Zhang B, Harris G, Magnotta VA: An MRI-based parcellation method for the temporal lobe. Neuroimage 2000; 11: 271-288. (Pubitemid 30194707)
2. Buchsbaum B, Hickok G, Humphries C: Role of left posterior STG in phonological processing for speech perception and production. Cogn Sci 2001; 25: 662-678.
3. Wong PC, Warrier CM, Penhune VB, Roy AK, Sadehh A, Parrish TB, Zatorre RJ: Volume of left Heschl's Gyrus and linguistic pitch learning. Cereb Cortex 2008; 18: 828-836. (Pubitemid 351398343)
4. Bellani M, Perlini C, Brambilla P: Language disturbances in schizophrenia. Epidemiol Psichiatr Soc 2009; 18: 314-317.
5. Molina V, Sanz J, Sarramea F, Luque R, Benito C, Palomo T: Dorsolateral prefrontal and superior temporal volume deficits in firstepisode psychoses that evolve into schizophrenia. Eur Arch Psychiatry Clin Neurosci 2006; 256: 106-111.
6. Sumich A, Chitnis XA, Fannon DG, O'Ceallaigh S, Doku VC, Falrowicz A, Marshall N, Matthew VM, Potter M, Sharma T: Temporal lobe abnormalities in first-episode psychosis. Am J Psychiatry 2002; 159: 1232-1235.
7. Rajarethinam RP, DeQuardo JR, Nalepa R, Tandon R: Superior temporal gyrus in schizophrenia: A volumetric magnetic resonance imaging study. Schizophr Res 2000; 41: 303-312. (Pubitemid 30077472)
8. Pearlson GD: Superior temporal gyrus and planum temporale in schizophrenia: A selective review. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21: 1203-1229. (Pubitemid 28046696)
9. Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, Feiner D, Rotrosen J, Wolkin A: Volumetric measure of the frontal and temporal lobe regions in schizophrenia: Relationship to negative symptoms. Arch Gen Psychiatry 2000; 57: 471-480. (Pubitemid 30257261)
10. Horn H, Federspiel A, Wirth M, Mueller TJ, Wiest R, Wang JJ, Strik W: Structural and metabolic changes in language areas linked to formal thought disorder. Br J Psychiatry 2009; 194: 130-138.
11. Tavano A, Sponda S, Fabbro F, Perlini C, Rambaldelli G, Ferro A, Cerruti S, Tansella M, Brambilla P: Specific linguistic and pragmatic deficits in Italian patients with schizophrenia. Schizophr Res 2008; 102: 53-62.
12. Tosato S, Dazzan P, Collier D: Association between the neuregulin 1 gene and schizophrenia: A systematic review. Schizophr Bull 2005; 31: 613-617. (Pubitemid 41253313)
13. Munafo MR, Thiselton DL, Clark TG, Flint J: Association of the NRG1 gene and schizophrenia: A meta-analysis. Mol Psychiatry 2006; 11: 539-546.
14. Tosato S, Lasalvia A: The contribution of epidemiology to defining the most appropriate approach to genetic research on schizophrenia. Epidemiol Psichiatr Soc 2009; 18: 81-90.
15. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877-892. (Pubitemid 135750519)
16. Hall D, Gogos JA, Karayiorgou M: The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 2004; 3: 240-248. (Pubitemid 39005679)
17. Bakker SC, Hoogendoorn ML, Selten JP, Verduijn W, Pearson PL, Sinke RJ, Kahn RS: Neuregulin 1: Genetic support for schizophrenia subtypes. Mol Psychiatry 2004; 9: 1061-1063. (Pubitemid 40065448)
18. Corvin AP, Morris DW, McGhee K, Schwaiger S, Scully P, Quinn J, Meagher D, Clair DS, Waddington JL, Gill M: Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the neuregulin-1 locus. Mol Psychiatry 2004; 9: 208-213.
19. Zhao X, Shi Y, Tang J, Tang R, Yu L, Gu N, Feng G, Zhu S, Liu H, Xing Y, Zhao S, Sang H, Guan Y, St Clair D, He L: A case control and family based association study of the neuregulin1 gene and schizophrenia. J Med Genet 2004; 41: 31-34. (Pubitemid 38125684)
20. Benzel I, Bansal A, Browning BL, Galwey NW, Maycox PR, McGinnis R, Smart D, St Clair D, Yates P, Purvis I: Interactions among genes in the ErbB-neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct 2007; 3: 31.
21. Li T, Stefansson H, Gudfinnsson E, Cai G, Liu X, Murray RM, Steinthorsdottir V, Januel D, Gudnadottir VG, Petursson H, Ingason A, Gulcher JR, Stefansson K, Collier DA: Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/ Scottish risk haplotype. Mol Psychiatry 2004; 9: 698-704. (Pubitemid 38932174)
22. Petryshen TL, Middleton FA, Kirby A, Aldinger KA, Purcell S, Tahl AR, Morley CP, McGann L, Gentile KL, Rockwell GN, Medeiros HM, Carvalho C, Macedo A, Dourado A, Valente J, Ferreira CP, Patterson NJ, Azevedo MH, Daly MJ, Pato CN, Pato MT, Sklar P: Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry 2005; 10: 328, 366-374.
23. Lachman HM, Pedrosa E, Nolan KA, Glass M, Ye K, Saito T: Analysis of polymorphisms in at-rich domains of neuregulin 1 gene in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006; 141B:102-109. (Pubitemid 43065474)
24. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperaviciute D, Gennarelli M, Strittmatter WJ, Bonvicini C, Rossi G, Jayathilake K, Cola PA, McEvoy JP, Keefe RS, Fisher EM, St Jean PL, Giegling I, Hartmann AM, Moller HJ, Ruppert A, Fraser G, Crombie C, Middleton LT, St Clair D, Roses AD, Muglia P, Francks C, Rujescu D, Meltzer HY, Goldstein DB: A genome-wide investigation of SNPS and CNVS in schizophrenia. PLoS Genet 2009; 5:e1000373.
25. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Crowe RR, Oksenberg JR, Mirel DB, Kendler KS, Freedman R, Gejman PV: Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753-757.
26. Athanasiu L, Mattingsdal M, Kahler AK, Brown A, Gustafsson O, Agartz I, Giegling I, Muglia P, Cichon S, Rietschel M, Pietilainen OP, Peltonen L, Bramon E, Collier D, Clair DS, Sigurdsson E, Petursson H, Rujescu D, Melle I, Steen VM, Djurovic S, Andreassen OA: Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res 2010; 44: 748-753.
27. Mei L, Xiong WC: Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008; 9: 437-452. (Pubitemid 351704944)
28. Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K: Neuregulin 1 and schizophrenia. Ann Med 2004; 36: 62-71. (Pubitemid 38230700)
29. Law A: Schizophrenia. 4. Neuregulin-1 in the human brain. Am J Psychiatry 2003; 160: 1392.
30. Rio C, Rieff HI, Qi P, Khurana TS, Corfas G: Neuregulin and erbB receptors play a critical role in neuronal migration. Neuron 1997; 19: 39-50. (Pubitemid 27332992)
31. Yau HJ, Wang HF, Lai C, Liu FC: Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: Preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb Cortex 2003; 13: 252-264. (Pubitemid 36236672)
32. Anton ES, Marchionni MA, Lee KF, Rakic P: Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development 1997; 124: 3501-3510. (Pubitemid 27470034)
33. Steiner H, Blum M, Kitai ST, Fedi P: Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp Neurol 1999; 159: 494-503. (Pubitemid 29485235)
34. Liu Y, Ford B, Mann MA, Fischbach GD: Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci 2001; 21: 5660-5669. (Pubitemid 32692164)
35. Okada M, Corfas G: Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse. Hippocampus 2004; 14: 337-344. (Pubitemid 38594409)
36. Rieff HI, Raetzman LT, Sapp DW, Yeh HH, Siegel RE, Corfas G: Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci 1999; 19: 10757-10766. (Pubitemid 30235722)
37. Vartanian T, Corfas G, Li Y, Fischbach GD, Stefansson K: A role for the acetylcholine receptor-inducing protein aria in oligodendrocyte development. Proc Natl Acad Sci USA 1994; 91: 11626-11630. (Pubitemid 24356397)
38. Fernandez PA, Tang DG, Cheng L, Prochiantz A, Mudge AW, Raff MC: Evidence that axon-derived neuregulin promotes oligodendrocyte survival in the developing rat optic nerve. Neuron 2000; 28: 81-90.
39. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL: GGF/ neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 1996; 17: 229-243. (Pubitemid 26296150)
40. Flores AI, Mallon BS, Matsui T, Ogawa W, Rosenzweig A, Okamoto T, Macklin WB: Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci 2000; 20: 7622-7630.
41. Buonanno A, Fischbach GD: Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol 2001; 11: 287-296. (Pubitemid 32524093)
42. Winseck AK, Caldero J, Ciutat D, Prevette D, Scott SA, Wang G, Esquerda JE, Oppenheim RW: In vivo analysis of Schwann cell programmed cell death in the embryonic chick: Regulation by axons and glial growth factor. J Neurosci 2002; 22: 4509-4521. (Pubitemid 37465667)
43. Trachtenberg JT, Thompson WJ: Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 1996; 379: 174-177. (Pubitemid 26020201)
44. Chen X, Wang XD, Chen G, Lin WW, Yao J, Gu XS: Study of in vivo differentiation of rat bone marrow stromal cells into Schwann cell-like cells. Microsurgery 2006; 26: 111-115.
45. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V: White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003; 60: 443-456. (Pubitemid 36539053)
46. Bellani M, Marzi CA, Brambilla P: Interhemispheric communication in schizophrenia. Epidemiol Psichiatr Soc 2009; 18: 19-22.
47. Owen MJ, Williams NM, O'Donovan MC: The molecular genetics of schizophrenia: New findings promise new insights. Mol Psychiatry 2004; 9: 14-27. (Pubitemid 38175078)
48. O'Donovan MC, Williams NM, Owen MJ: Recent advances in the genetics of schizophrenia. Hum Mol Genet 2003; 12:R125-R133. (Pubitemid 37259324)
49. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA: Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746-4751. (Pubitemid 32295047)
50. Moises HW, Zoega T, Gottesman II: The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2002; 2: 8.
51. Jessen KR, Mirsky R: The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 2005; 6: 671-682. (Pubitemid 43160316)
52. Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu X, Esper RM, Loeb JA, Shrager P, Chao MV, Falls DL, Role L, Salzer JL: Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 2005; 47: 681-694. (Pubitemid 41208007)
53. Harrison PJ, Law AJ: Neuregulin 1 and schizophrenia: Genetics, gene expression, and neurobiology. Biol Psychiatry 2006; 60: 132-140.
54. Becker T, Knapp M, Knudsen HC, Schene A, Tansella M, Thornicroft G, Vazquez-Barquero JL: The epsilon study of schizophrenia in five European countries. Design and methodology for standardising outcome measures and comparing patterns of care and service costs. Br J Psychiatry 1999; 175: 514-521.
55. World Health Organization: Schedules for Clinical Assessment in Neuropsychiatry (Scan), ed 2. Geneva, World Health Organization, 1994.
56. Ventura MA, Green MF, Shaner A, Liberman RP: Training and quality assurance with the brief psychiatric rating scale: 'the drift buster'. Int J Methods Psychiatr Res 1993; 3: 221-244.
57. Barbui C, Nose M, Rambaldelli G, Bonetto C, Levi D, Patten SB, Tansella M: Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research. Int J Methods Psychiatr Res 2005; 14: 151-157. (Pubitemid 41448730)
58. Nose M, Barbui C: A simple approach to manage dosages in drug-epidemiology research. Epidemiol Psichiatr Soc 2008; 17: 186-187.
59. Tosato S, Ruggeri M, Bonetto C, Bertani M, Marrella G, Lasalvia A, Cristofalo D, Aprili G, Tansella M, Dazzan P, Diforti M, Murray RM, Collier DA: Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:647-659. (Pubitemid 47077150)
60. Brambilla P, Harenski K, Nicoletti M, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC: MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res 2003; 37: 287-295. (Pubitemid 36579409)
61. Good PI: Resampling Methods: A Practical Guide to Data Analysis. Boston, Birkhäuser, 2001.
62. Prasad KM, Keshavan MS: Structural cerebral variations as useful endophenotypes in schizophrenia: Do they help construct 'extended endophenotypes'? Schizophr Bull 2008; 34: 774-790. (Pubitemid 351957553)
63. Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW: Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible? J Psychiatr Res 1998; 32: 161-167. (Pubitemid 28408280)
64. Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE, Bilker WB, Gur RC: Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry 2000; 57: 761-768. (Pubitemid 30650111)
65. Gur RE, Turetsky BI, Cowell PE, Finkelman C, Maany V, Grossman RI, Arnold SE, Bilker WB, Gur RC: Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry 2000; 57: 769-775. (Pubitemid 30650112)
66. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW: Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 2003; 160: 156-164. (Pubitemid 36042440)
67. Hof PR, Haroutunian V, Friedrich VL Jr., Byne W, Buitron C, Perl DP, Davis KL: Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 2003; 53: 1075-1085. (Pubitemid 36695083)
68. Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B: Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 2004; 161: 882-888. (Pubitemid 38625342)
69. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI: Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: A study from the Stanley Neuropathology Consortium. Schizophr Res 2004; 67: 269-275. (Pubitemid 38251458)
70. Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM, Benoit-Marand M, Chen C, Moore H, O'Donnell P, Brunner D, Corfas G: Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci USA 2007; 104: 8131-8136. (Pubitemid 47185887)
71. Addington AM, Gornick MC, Shaw P, Seal J, Gogtay N, Greenstein D, Clasen L, Coffey M, Gochman P, Long R, Rapoport JL: Neuregulin 1 (8p12) and childhood-onset schizophrenia: Susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol Psychiatry 2007; 12: 195-205. (Pubitemid 46160984)
72. McIntosh AM, Moorhead TW, Job D, Lymer GK, Munoz Maniega S, McKirdy J, Sussmann JE, Baig BJ, Bastin ME, Porteous D, Evans KL, Johnstone EC, Lawrie SM, Hall J: The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry 2008; 13: 1054-1059.